Occam Places Bastiano Sanna as CEO of Semma

Occam Places Bastiano Sanna as CEO of Semma

Semma Therapeutics is a cell therapy company founded by Doug Melton of Harvard University and financed by ARCH Venture, MPM, and F-Prime. The company was subsequently acquired by Vertex for approximately $1B in late 2019.

Bastiano Sanna was a first-time CEO, who brought a Ph.D. in pharmacology, experience in investment banking (Leerink), exposure to strategy & portfolio management (NIBR), and entrepreneurial operating chops as the “Number Two” at Magenta, a cell therapy company that subsequently went public.

About Occam Global

Occam Global is an executive recruiting and leadership advisory firm with specialties across technological fields including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.